Yüklüyor......
Incidence and risk of vaginal candidiasis associated with sodium–glucose cotransporter 2 inhibitors in real‐world practice for women with type 2 diabetes
AIMS/INTRODUCTION: The prevalence and risk of vaginal candidiasis before and after initiating sodium–glucose cotransporter 2 (SGLT2) inhibitors, although some clinical trials have been carried out, have not been adequately shown in real‐world practice. We investigated the incidence of vaginal Candid...
Kaydedildi:
| Yayımlandı: | J Diabetes Investig |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6400166/ https://ncbi.nlm.nih.gov/pubmed/30136398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12912 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|